1. Chilakamarthi U, Giribabu L. Photodynamic therapy: past, present and future. Chem Rec. 2017;17:775-802.
2. Cheng YJ, Hu JJ, Qin SY, Zhang AQ, Zhang XZ. Recent advances in functional mesoporous silica-based nanoplatforms for combinational photo-chemotherapy of cancer. Biomaterials. 2020;232:119738.
3. Fan W, Huang P, Chen X. Overcoming the Achilles’ heel of photodynamic therapy. Chem Soc Rev. 2016;45:6488-519.
4. Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69:363-85.
5. Chen J, Fan T, Xie Z, et al. Advances in nanomaterials for photodynamic therapy applications: status and challenges. Biomaterials. 2020;237:119827.
6. Sun W, Zhou Z, Pratx G, Chen X, Chen H. Nanoscintillator-mediated X-ray induced photodynamic therapy for deep-seated tumors: from concept to biomedical applications. Theranostics. 2020;10:1296-318.
7. Liu Z, Cao T, Xue Y, et al. Self-amplified photodynamic therapy through the O2 -mediated internalization of photosensitizers from a Ppa-bearing block copolymer. Angew Chem Int Ed. 2020;59:3711-7.
8. Tian J, Zhang W. Synthesis, self-assembly and applications of functional polymers based on porphyrins. Prog Polym Sci. 2019;95:65-117.
9. Yanovsky RL, Bartenstein DW, Rogers GS, Isakoff SJ, Chen ST. Photodynamic therapy for solid tumors: a review of the literature. Photodermatol Photoimmunol Photomed. 2019;35:295-303.
10. Wang K, Yu B, Pathak JL. An update in clinical utilization of photodynamic therapy for lung cancer. J Cancer. 2021;12:1154-60.
11. Zhang Q, Wu L, Liu S, et al. Targeted nanobody complex enhanced photodynamic therapy for lung cancer by overcoming tumor microenvironment. Cancer Cell Int. 2020;20:570.
12. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7-30.
13. Wu W, Shi L, Duan Y, et al. Nanobody modified high-performance AIE photosensitizer nanoparticles for precise photodynamic oral cancer therapy of patient-derived tumor xenograft. Biomaterials. 2021;274:120870.
14. Lu K, He C, Lin W. Nanoscale metal-organic framework for highly effective photodynamic therapy of resistant head and neck cancer. J Am Chem Soc. 2014;136:16712-5.
15. Rettig EM, D’Souza G. Epidemiology of head and neck cancer. Surg Oncol Clin N Am. 2015;24:379-96.
16. Quirk BJ, Brandal G, Donlon S, et al. Photodynamic therapy (PDT) for malignant brain tumors - where do we stand? Photodiagnosis Photodyn Ther. 2015;12:530-44.
17. Li X, Lovell JF, Yoon J, Chen X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol. 2020;17:657-74.
18. Wang Y, Wang H, Zhou L, et al. Photodynamic therapy of pancreatic cancer: where have we come from and where are we going? Photodiagnosis Photodyn Ther. 2020;31:101876.
19. Zhang Z, Li A, Min X, et al. An ROS-sensitive tegafur-PpIX-heterodimer-loaded in situ injectable thermosensitive hydrogel for photodynamic therapy combined with chemotherapy to enhance the tegafur-based treatment of breast cancer. Biomater Sci. 2021;9:221-37.
20. Li M, Xu Y, Peng X, Kim JS. From low to No O2-dependent hypoxia photodynamic therapy (hPDT): a new perspective. ACC Chem Res. 2022;55:3253-64.
21. Qiu M, Wang D, Huang H, et al. A regioselectively oxidized 2D Bi/BiOx lateral nano-heterostructure for hypoxic photodynamic therapy. Adv Mater. 2021;33:e2102562.
22. Duan Z, Luo Q, Dai X, et al. Synergistic therapy of a naturally inspired glycopolymer-based biomimetic nanomedicine harnessing tumor genomic instability. Adv Mater. 2021;33:e2104594.
23. Nguyen VN, Yan Y, Zhao J, Yoon J. Heavy-atom-free photosensitizers: from molecular design to applications in the photodynamic therapy of cancer. ACC Chem Res. 2021;54:207-20.
24. O’Connor AE, Gallagher WM, Byrne AT. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol. 2009;85:1053-74.
25. Jin CS, Lovell JF, Chen J, Zheng G. Ablation of hypoxic tumors with dose-equivalent photothermal, but not photodynamic, therapy using a nanostructured porphyrin assembly. ACS Nano. 2013;7:2541-50.
26. Moan J, Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res. 1985;45:1608-10.
27. Li Y, Zhang W, Niu J, Chen Y. Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles. ACS Nano. 2012;6:5164-73.
28. Mattila H, Khorobrykh S, Havurinne V, Tyystjärvi E. Reactive oxygen species: reactions and detection from photosynthetic tissues. J Photochem Photobiol B. 2015;152:176-214.
29. Li X, Kwon N, Guo T, Liu Z, Yoon J. Innovative strategies for hypoxic-tumor photodynamic therapy. Angew Chem Int Ed. 2018;57:11522-31.
30. Sahu A, Kwon I, Tae G. Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia. Biomaterials. 2020;228:119578.
31. Sahu A, Choi WI, Tae G. Recent progress in the design of hypoxia-specific nano drug delivery systems for cancer therapy. Adv Ther. 2018;1:1800026.
32. LaGory EL, Giaccia AJ. The ever-expanding role of HIF in tumour and stromal biology. Nat Cell Biol. 2016;18:356-65.
33. Rankin EB, Giaccia AJ. Hypoxic control of metastasis. Science. 2016;352:175-80.
34. Rodríguez ME, Catrinacio C, Ropolo A, Rivarola VA, Vaccaro MI. A novel HIF-1α/VMP1-autophagic pathway induces resistance to photodynamic therapy in colon cancer cells. Photochem Photobiol Sci. 2017;16:1631-42.
35. de Souza AL, Marra K, Gunn J, et al. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer. Br J Cancer. 2016;115:805-13.
36. Ding B, Shao S, Yu C, et al. Large-pore mesoporous-silica-coated upconversion nanoparticles as multifunctional immunoadjuvants with ultrahigh photosensitizer and antigen loading efficiency for improved cancer photodynamic immunotherapy. Adv Mater. 2018;30:e1802479.
37. Zhang Y, Bo S, Feng T, et al. A versatile theranostic nanoemulsion for architecture-dependent multimodal imaging and dually augmented photodynamic therapy. Adv Mater. 2019;31:e1806444.
38. Zhu H, Li Q, Shi B, et al. Dual-emissive platinum(II) metallacage with a sensitive oxygen response for imaging of hypoxia and imaging-guided chemotherapy. Angew Chem Int Ed. 2020;59:20208-14.
39. Liu Y, Liu CZ, Wang ZK, et al. Supramolecular organic frameworks improve the safety of clinically used porphyrin photodynamic agents and maintain their antitumor efficacy. Biomaterials. 2022;284:121467.
40. Caruso E, Cerbara M, Malacarne MC, Marras E, Monti E, Gariboldi MB. Synthesis and photodynamic activity of novel non-symmetrical diaryl porphyrins against cancer cell lines. J Photochem Photobiol B. 2019;195:39-50.
41. Jaque D, Martínez Maestro L, del Rosal B, et al. Nanoparticles for photothermal therapies. Nanoscale. 2014;6:9494-530.
42. Chen Q, Xu L, Liang C, Wang C, Peng R, Liu Z. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Nat Commun. 2016;7:13193.
43. Li X, Peng XH, Zheng BD, et al. New application of phthalocyanine molecules: from photodynamic therapy to photothermal therapy by means of structural regulation rather than formation of aggregates. Chem Sci. 2018;9:2098-104.
44. Song CW, Rhee JG, Levitt SH. Effect of hyperthermia on hypoxic cell fraction in tumor. Int J Radiat Oncol Biol Phys. 1982;8:851-6.
45. Brizel DM, Scully SP, Harrelson JM, et al. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res. 1996;56:5347-50.
46. Li W, Wang L, Sun T, et al. Characterization of nanoparticles combining polyamine detection with photodynamic therapy. Commun Biol. 2021;4:803.
47. Wang X, Chen M, Zhou J, Zhang X. HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review). Int J Oncol. 2014;45:18-30.
48. Sheng D, Liu T, Deng L, et al. Perfluorooctyl bromide & indocyanine green co-loaded nanoliposomes for enhanced multimodal imaging-guided phototherapy. Biomaterials. 2018;165:1-13.
49. Lin J, Wang M, Hu H, et al. Multimodal-imaging-guided cancer phototherapy by versatile biomimetic theranostics with UV and γ-irradiation protection. Adv Mater. 2016;28:3273-9.
50. Ding M, Shao K, Wu L, et al. A NO/ROS/RNS cascaded-releasing nano-platform for gas/PDT/PTT/immunotherapy of tumors. Biomater Sci. 2021;9:5824-40.
51. Li Y, Lu W, Huang Q, Huang M, Li C, Chen W. Copper sulfide nanoparticles for photothermal ablation of tumor cells. Nanomedicine. 2010;5:1161-71.
52. Li L, Rashidi LH, Yao M, et al. CuS nanoagents for photodynamic and photothermal therapies: phenomena and possible mechanisms. Photodign Photody Ther. 2017;19:5-14.
53. Cheng L, Gong H, Zhu W, et al. PEGylated Prussian blue nanocubes as a theranostic agent for simultaneous cancer imaging and photothermal therapy. Biomaterials. 2014;35:9844-52.
54. Cai X, Gao W, Ma M, et al. A prussian blue-based core-shell hollow-structured mesoporous nanoparticle as a smart theranostic agent with ultrahigh pH-responsive longitudinal relaxivity. Adv Mater. 2015;27:6382-9.
55. Sahu A, Lee JH, Lee HG, Jeong YY, Tae G. Prussian blue/serum albumin/indocyanine green as a multifunctional nanotheranostic agent for bimodal imaging guided laser mediated combinatorial phototherapy. J Control Release. 2016;236:90-9.
56. Sun L, Li Q, Hou M, et al. Light-activatable Chlorin e6 (Ce6)-imbedded erythrocyte membrane vesicles camouflaged Prussian blue nanoparticles for synergistic photothermal and photodynamic therapies of cancer. Biomater Sci. 2018;6:2881-95.
57. Yang R, Hou M, Gao Y, et al. Indocyanine green-modified hollow mesoporous Prussian blue nanoparticles loading doxorubicin for fluorescence-guided tri-modal combination therapy of cancer. Nanoscale. 2019;11:5717-31.
58. Zhang D, Wu M, Zeng Y, et al. Chlorin e6 conjugated poly(dopamine) nanospheres as PDT/PTT dual-modal therapeutic agents for enhanced cancer therapy. ACS Appl Mater Interfaces. 2015;7:8176-87.
59. Feng L, Tao D, Dong Z, et al. Near-infrared light activation of quenched liposomal Ce6 for synergistic cancer phototherapy with effective skin protection. Biomaterials. 2017;127:13-24.
60. Zeng W, Zhang H, Deng Y, et al. Dual-response oxygen-generating MnO2 nanoparticles with polydopamine modification for combined photothermal-photodynamic therapy. Chem Eng J. 2020;389:124494.
61. Vijayaraghavan P, Liu CH, Vankayala R, Chiang CS, Hwang KC. Designing multi-branched gold nanoechinus for NIR light activated dual modal photodynamic and photothermal therapy in the second biological window. Adv Mater. 2014;26:6689-95.
62. Li W, Guo X, Kong F, et al. Overcoming photodynamic resistance and tumor targeting dual-therapy mediated by indocyanine green conjugated gold nanospheres. J Control Release. 2017;258:171-81.
63. Yeo ELL, Cheah JU, Lim BY, Thong PSP, Soo KC, Kah JCY. Protein corona around gold nanorods as a drug carrier for multimodal cancer therapy. ACS Biomater Sci Eng. 2017;3:1039-50.
64. Yan X, Hu H, Lin J, et al. Optical and photoacoustic dual-modality imaging guided synergistic photodynamic/photothermal therapies. Nanoscale. 2015;7:2520-6.
65. Ding YF, Kwong CHT, Li S, et al. Supramolecular nanomedicine derived from cucurbit[7]uril-conjugated nano-graphene oxide for multi-modality cancer therapy. Biomater Sci. 2021;9:3804-13.
66. Zhang X, Ong’achwa Machuki J, Pan W, et al. Carbon nitride hollow theranostic nanoregulators executing laser-activatable water splitting for enhanced ultrasound/fluorescence imaging and cooperative phototherapy. ACS Nano. 2020;14:4045-60.
67. Lee G, Lee JH, Choi W, Kim C, Hahn SK. Hyaluronate-black phosphorus-upconversion nanoparticle complex for non-invasive theranosis of skin cancer. Biomacromolecules. 2022;23:3602-11.
68. Li L, Rashidi LH, Yao M, et al. CuS nanoagents for photodynamic and photothermal therapies: phenomena and possible mechanisms. Photodiagnosis Photodyn Ther. 2017;19:5-14.
69. Zhang W, Yu L, Jiang Y, Guo C. Phycocyanin-functionalized black phosphorus quantum dots enhance PDT/PTT therapy by inducing ROS and irreparable DNA damage. Biomater Sci. 2021;9:5302-18.
70. Yong Y, Zhou L, Gu Z, et al. WS2 nanosheet as a new photosensitizer carrier for combined photodynamic and photothermal therapy of cancer cells. Nanoscale. 2014;6:10394-403.
71. Song L, Chen B, Qin Z, et al. Temperature-dependent CAT-like RGD-BPNS@SMFN nanoplatform for PTT-PDT self-synergetic tumor phototherapy. Adv Healthc Mater. 2022;11:e2102298.
72. Feng L, Cheng L, Dong Z, et al. Theranostic liposomes with hypoxia-activated prodrug to effectively destruct hypoxic tumors post-photodynamic therapy. ACS Nano. 2017;11:927-37.
73. He H, Du L, Xue H, Wu J, Shuai X. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy. Acta Biomater. 2022;149:297-306.
74. Lin LS, Huang T, Song J, et al. Synthesis of copper peroxide nanodots for H2O2 self-supplying chemodynamic therapy. J Am Chem Soc. 2019;141:9937-45.
75. Fan JX, Peng MY, Wang H, et al. Engineered bacterial bioreactor for tumor therapy via fenton-like reaction with localized H2O2 generation. Adv Mater. 2019;31:e1808278.
76. Hu JJ, Chen Y, Li ZH, Peng SY, Sun Y, Zhang XZ. Augment of oxidative damage with enhanced photodynamic process and MTH1 inhibition for tumor therapy. Nano Lett. 2019;19:5568-76.
77. Tang Z, Liu Y, He M, Bu W. Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions. Angew Chem Int Ed. 2019;58:946-56.
78. Hwang E, Jung HS. Metal-organic complex-based chemodynamic therapy agents for cancer therapy. Chem Commun. 2020;56:8332-41.
79. Lin H, Chen Y, Shi J. Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy. Chem Soc Rev. 2018;47:1938-58.
80. Hao YN, Zhang WX, Gao YR, Wei YN, Shu Y, Wang JH. State-of-the-art advances of copper-based nanostructures in the enhancement of chemodynamic therapy. J Mater Chem B. 2021;9:250-66.
81. Wang W, Jin Y, Xu Z, et al. Stimuli-activatable nanomedicines for chemodynamic therapy of cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020;12:e1614.
82. Chudal L, Pandey NK, Phan J, Johnson O, Li X, Chen W. Investigation of PPIX-Lipo-MnO2 to enhance photodynamic therapy by improving tumor hypoxia. Mater Sci Eng C. 2019;104:109979.
83. Chudal L, Pandey NK, Phan J, et al. Copper-cysteamine nanoparticles as a heterogeneous fenton-like catalyst for highly selective cancer treatment. ACS Appl Bio Mater. 2020;3:1804-14.
84. Liu Y, Zhen W, Jin L, et al. All-in-one theranostic nanoagent with enhanced reactive oxygen species generation and modulating tumor microenvironment ability for effective tumor eradication. ACS Nano. 2018;12:4886-93.
85. Kim J, Cho HR, Jeon H, et al. Continuous O2-evolving MnFe2O4 nanoparticle-anchored mesoporous silica nanoparticles for efficient photodynamic therapy in hypoxic cancer. J Am Chem Soc. 2017;139:10992-5.
86. Liang H, Guo J, Shi Y, Zhao G, Sun S, Sun X. Porous yolk-shell Fe/Fe3O4 nanoparticles with controlled exposure of highly active Fe0 for cancer therapy. Biomaterials. 2021;268:120530.
87. Shen Z, Song J, Yung BC, Zhou Z, Wu A, Chen X. Emerging strategies of cancer therapy based on ferroptosis. Adv Mater. 2018;30:e1704007.
88. Shen Z, Liu T, Li Y, et al. Fenton-reaction-acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors. ACS Nano. 2018;12:11355-65.
89. Jiang Q, Wang K, Zhang X, et al. Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy. Small. 2020;16:e2001704.
90. Yang B, Dai Z, Zhang G, et al. Ultrasmall ternary FePtMn nanocrystals with acidity-triggered dual-ions release and hypoxia relief for multimodal synergistic chemodynamic/photodynamic/photothermal cancer therapy. Adv Healthc Mater. 2020;9:e1901634.
91. Yang B, Ding L, Yao H, Chen Y, Shi J. A metal-organic framework (MOF) fenton nanoagent-enabled nanocatalytic cancer therapy in synergy with autophagy inhibition. Adv Mater. 2020;32:e1907152.
92. Park E, Chung SW. ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis. 2019;10:822.
93. Zhao P, Tang Z, Chen X, et al. Ferrous-cysteine-phosphotungstate nanoagent with neutral pH fenton reaction activity for enhanced cancer chemodynamic therapy. Mater Horiz. 2019;6:369-74.
94. Wang X, Wu M, Zhang X, et al. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy. J Nanobiotechnol. 2021;19:204.
95. Zhou L, Wu Y, Meng X, et al. Dye-anchored MnO nanoparticles targeting tumor and inducing enhanced phototherapy effect via mitochondria-mediated pathway. Small. 2018;14:e1801008.
96. Hou H, Huang X, Wei G, Xu F, Wang Y, Zhou S. Fenton reaction-assisted photodynamic therapy for cancer with multifunctional magnetic nanoparticles. ACS Appl Mater Interfaces. 2019;11:29579-92.
97. Feng W, Han X, Wang R, et al. Nanocatalysts-augmented and photothermal-enhanced tumor-specific sequential nanocatalytic therapy in both NIR-I and NIR-II biowindows. Adv Mater. 2019;31:e1805919.
98. Bokare AD, Choi W. Review of iron-free Fenton-like systems for activating H2O2 in advanced oxidation processes. J Hazard Mater. 2014;275:121-35.
99. Yao M, Ma L, Li L, et al. A new modality for cancer treatment-nanoparticle mediated microwave induced photodynamic therapy. J Biomed Nanotechnol. 2016;12:1835-51.
100. Chen J, Fan T, Xie Z, et al. Advances in nanomaterials for photodynamic therapy applications: status and challenges. Biomaterials. 2020;237:119827.
101. Nieto-Juarez JI, Pierzchła K, Sienkiewicz A, Kohn T. Inactivation of MS2 coliphage in Fenton and Fenton-like systems: role of transition metals, hydrogen peroxide and sunlight. Environ Sci Technol. 2010;44:3351-6.
102. Salazar R, Brillas E, Sirés I. Finding the best Fe2+/Cu2+ combination for the solar photoelectro-fenton treatment of simulated wastewater containing the industrial textile dye disperse blue 3. Appl Catal B Environ. 2012;115-6:107-16.
103. Speisky H, Gómez M, Carrasco-Pozo C, Pastene E, Lopez-Alarcón C, Olea-Azar C. Cu(I)-glutathione complex: a potential source of superoxide radicals generation. Bioorg Med Chem. 2008;16:6568-74.
104. Li T, Zhou J, Wang L, et al. Photo-fenton-like metal-protein self-assemblies as multifunctional tumor theranostic agent. Adv Healthc Mater. 2019;8:e1900192.
105. Liu Y, Wu J, Jin Y, et al. Copper(I) phosphide nanocrystals for in situ self-generation magnetic resonance imaging-guided photothermal-enhanced chemodynamic synergetic therapy resisting deep-seated tumor. Adv Funct Mater. 2019;29:1904678.
106. Wan H, Zhang Y, Zhang W, Zou H. Robust two-photon visualized nanocarrier with dual targeting ability for controlled chemo-photodynamic synergistic treatment of cancer. ACS Appl Mater Interfaces. 2015;7:9608-18.
107. Wang Z, Ma R, Yan L, Chen X, Zhu G. Combined chemotherapy and photodynamic therapy using a nanohybrid based on layered double hydroxides to conquer cisplatin resistance. Chem Commun. 2015;51:11587-90.
108. Su X, Wang WJ, Cao Q, et al. A carbonic anhydrase IX (CAIX)-anchored rhenium(I) photosensitizer evokes pyroptosis for enhanced anti-tumor immunity. Angew Chem Int Ed. 2022;61:e202115800.
109. Wang M, Wu M, Liu X, et al. Pyroptosis remodeling tumor microenvironment to enhance pancreatic cancer immunotherapy driven by membrane anchoring photosensitizer. Adv Sci. 2022;9:e2202914.
110. Guo W, Li Z, Huang H, et al. VB12-sericin-PBLG-IR780 nanomicelles for programming cell pyroptosis via photothermal (PTT)/photodynamic (PDT) effect-induced mitochondrial DNA (mitoDNA) oxidative damage. ACS Appl Mater Interfaces. 2022;14:17008-21.
111. Lu Y, Xu F, Wang Y, et al. Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate. Biomaterials. 2021;278:121167.
112. Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348:56-61.
113. Liu X, Bao X, Hu M, et al. Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer. Nature. 2020;588:693-8.
114. Yang B, Gao J, Pei Q, Xu H, Yu H. Engineering prodrug nanomedicine for cancer immunotherapy. Adv Sci. 2020;7:2002365.
115. Chen Q, Chen M, Liu Z. Local biomaterials-assisted cancer immunotherapy to trigger systemic antitumor responses. Chem Soc Rev. 2019;48:5506-26.
116. Shi Y, Lammers T. Combining nanomedicine and immunotherapy. ACC Chem Res. 2019;52:1543-54.
117. Smyth MJ, Ngiow SF, Ribas A, Teng MW. Combination cancer immunotherapies tailored to the tumour microenvironment. Nat Rev Clin Oncol. 2016;13:143-58.
118. Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat Immunol. 2022;23:487-500.
119. Zhang Z, Zhang Y, Xia S, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579:415-20.
120. Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol. 2017;17:97-111.
121. Xiong H, Ma X, Wang X, et al. Inspired epigenetic modulation synergy with adenosine inhibition elicits pyroptosis and potentiates cancer immunotherapy. Adv Funct Mater. 2021;31:2100007.
122. Han X, Cheng K, Xu Y, et al. Modularly designed peptide nanoprodrug augments antitumor immunity of PD-L1 checkpoint blockade by targeting indoleamine 2,3-dioxygenase. J Am Chem Soc. 2020;142:2490-6.
123. Cheng K, Ding Y, Zhao Y, et al. Sequentially responsive therapeutic peptide assembling nanoparticles for dual-targeted cancer immunotherapy. Nano Lett. 2018;18:3250-8.
124. Zhang Q, Guo X, Cheng Y, et al. Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment. Signal Transduct Target Ther. 2020;5:58.
125. Wan D, Yang Y, Liu Y, et al. Sequential depletion of myeloid-derived suppressor cells and tumor cells with a dual-pH-sensitive conjugated micelle system for cancer chemoimmunotherapy. J Control Release. 2020;317:43-56.
126. Qiu W, Su W, Xu J, et al. Immunomodulatory-photodynamic nanostimulators for invoking pyroptosis to augment tumor immunotherapy. Adv Healthc Mater. 2022;11:e2201233.
127. Zhou F, Wu S, Yuan Y, Chen WR, Xing D. Mitochondria-targeting photoacoustic therapy using single-walled carbon nanotubes. Small. 2012;8:1543-50.
128. Chen H, Wan Y, Cui X, Li S, Lee CS. Recent advances in hypoxia-overcoming strategy of aggregation-induced emission photosensitizers for efficient photodynamic therapy. Adv Healthc Mater. 2021;10:e2101607.
129. Zhang R, Zeng Q, Li X, Xing D, Zhang T. Versatile gadolinium(III)-phthalocyaninate photoagent for MR/PA imaging-guided parallel photocavitation and photodynamic oxidation at single-laser irradiation. Biomaterials. 2021;275:120993.
130. Yang M, Yang T, Mao C. Enhancement of photodynamic cancer therapy by physical and chemical factors. Angew Chem Int Ed. 2019;58:14066-80.
131. Zhou H, Liu Z, Zhang Z, et al. Copper-cysteamine nanoparticle-mediated microwave dynamic therapy improves cancer treatment with induction of ferroptosis. Bioact Mater. 2023;24:322-30.
132. Wu Q, Xia N, Long D, et al. Dual-functional supernanoparticles with microwave dynamic therapy and microwave thermal therapy. Nano Lett. 2019;19:5277-86.
133. Ma L, Chen W, Schatte G, et al. A new Cu-cysteamine complex: structure and optical properties. J Mater Chem C. 2014;2:4239-46.
134. Huang X, Wan F, Ma L, et al. Investigation of copper-cysteamine nanoparticles as a new photosensitizer for anti-hepatocellular carcinoma. Cancer Biol Ther. 2019;20:812-25.
135. Pandey NK, Chudal L, Phan J, et al. A facile method for the synthesis of copper-cysteamine nanoparticles and study of ROS production for cancer treatment. J Mater Chem B. 2019;7:6630-42.
136. Wang P, Wang X, Ma L, et al. Nanosonosensitization by using copper-cysteamine nanoparticles augmented sonodynamic cancer treatment. Part Part Syst Charact. 2018;35:1700378.
137. Ma L, Zou X, Chen W. A new X-ray activated nanoparticle photosensitizer for cancer treatment. J Biomed Nanotechnol. 2014;10:1501-8.
138. Shrestha S, Wu J, Sah B, et al. X-ray induced photodynamic therapy with copper-cysteamine nanoparticles in mice tumors. Proc Natl Acad Sci USA. 2019;116:16823-8.
139. Shi L, Liu P, Wu J, et al. The effectiveness and safety of X-PDT for cutaneous squamous cell carcinoma and melanoma. Nanomedicine. 2019;14:2027-43.
140. Chong LM, Tng DJH, Tan LLY, Chua MLK, Zhang Y. Recent advances in radiation therapy and photodynamic therapy. Appl Phys Rev. 2021;8:041322.
141. Sah B, Wu J, Vanasse A, et al. Effects of nanoparticle size and radiation energy on copper-cysteamine nanoparticles for X-ray induced photodynamic therapy. Nanomaterials. 2020;10:1087.
142. Chen X, Liu J, Li Y, et al. Study of copper-cysteamine based X-ray induced photodynamic therapy and its effects on cancer cell proliferation and migration in a clinical mimic setting. Bioact Mater. 2022;7:504-14.
143. Gawande MB, Goswami A, Felpin FX, et al. Cu and Cu-based nanoparticles: synthesis and applications in catalysis. Chem Rev. 2016;116:3722-811.
144. Wu T, Liang X, Liu X, et al. Induction of ferroptosis in response to graphene quantum dots through mitochondrial oxidative stress in microglia. Part Fibre Toxicol. 2020;17:30.
145. Chu X, Li K, Guo H, et al. Exploration of graphitic-C3N4 quantum dots for microwave-induced photodynamic therapy. ACS Biomater Sci Eng. 2017;3:1836-44.
146. Pandey NK, Xiong W, Wang L, et al. Aggregation-induced emission luminogens for highly effective microwave dynamic therapy. Bioact Mater. 2022;7:112-25.
147. Chu X, Mao L, Johnson O, et al. Exploration of TiO2 nanoparticle mediated microdynamic therapy on cancer treatment. Nanomedicine. 2019;18:272-81.
148. Wang S, Tian R, Zhang X, et al. Beyond photo: xdynamic therapies in fighting cancer. Adv Mater. 2021;33:e2007488.
149. Allen C, Her S, Jaffray DA. Radiotherapy for cancer: present and future. Adv Drug Deliv Rev. 2017;109:1-2.
150. Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol. 2019;25:101084.
151. Chen W, Zhang J. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J Nanosci Nanotechnol. 2006;6:1159-66.
152. Chen W. Nanoparticle fluorescence based technology for biological applications. J Nanosci Nanotechnol. 2008;8:1019-51.
153. Zou X, Yao M, Ma L, et al. X-ray-induced nanoparticle-based photodynamic therapy of cancer. Nanomedicine. 2014;9:2339-51.
154. Liu Z, Xiong L, Ouyang G, et al. Investigation of copper cysteamine nanoparticles as a new type of radiosensitiers for colorectal carcinoma treatment. Sci Rep. 2017;7:9290.
155. Liu F, Chen W, Wang SP, Joly AG. Investigation of water-soluble X-ray luminescence nanoparticles for photodynamic activation. Appl Phys Lett. 2008;92:43901.
156. Homayoni H, Sahi S, Ma L, et al. X-ray excited luminescence and persistent luminescence of Sr2MgSi2O7:Eu2+, Dy3+ and their associations with synthesis conditions. J Lumin. 2018;198:132-7.
157. Ma L, Zou X, Chen W. A new X-ray activated nanoparticle photosensitizer for cancer treatment. J Biomed Nanotechnol. 2014;10:1501-8.
158. Chen X, Liu J, Li Y, et al. Study of copper-cysteamine based X-ray induced photodynamic therapy and its effects on cancer cell proliferation and migration in a clinical mimic setting. Bioact Mater. 2022;7:504-14.
159. Shrestha S, Wu J, Sah B, et al. X-ray induced photodynamic therapy with copper-cysteamine nanoparticles in mice tumors. Proc Natl Acad Sci USA. 2019;116:16823-8.
160. Wang J, Hao L, Li X, Liu S. W18O49@EP nanoparticles improve the anti-tumor effect of radiotherapy and photodynamic therapy by avoiding the limitation of hypoxia. Front Bioeng Biotechnol. 2022;10:1060467.
161. Gong L, Zhang Y, Zhao J, et al. All-in-one biomimetic nanoplatform based on hollow polydopamine nanoparticles for synergistically enhanced radiotherapy of colon cancer. Small. 2022;18:2205198.
162. Dan Q, Hu D, Ge Y, et al. Ultrasmall theranostic nanozymes to modulate tumor hypoxia for augmenting photodynamic therapy and radiotherapy. Biomater Sci. 2020;8:973-87.
Comments
Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any queries or need any help, please contact us at support@oaepublish.com.